J10 J12
Conditions
Interventions
Group 1: All patients with cancer who suffer from virus infection with CRV in participating centres since 2018-10-01
Sponsors
Universitätsklinikum Jena Klinik für Innere Medizin IIAbt. Hämatologie/Internistische Onkologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with malignancies and a proven virological infection with CRV: (Influenza, RSV, MPV, Parainfluenza, Rhinovirus, Coronavirus, Bocavirus, Adenovirus) in participating centers in Germany starting october 2015
Exclusion criteria
Exclusion criteria: missing inclusing criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of the CRV rate in cancer patients as a random number | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of the rate of mortality of patients with cancer and additionally detected CRV infection, Definition of risk factors for a progress of CRV infections for patients with malignancies - Evaluation of the influence of a specific antiviral therapy of the progress | — |
Countries
Germany
Contacts
Public ContactChristiane Clauß
Universitätsklinikum Jena Klinik für Innere Medizin IIAbt. Hämatologie/Internistische OnkologieStudienzentrale
Outcome results
None listed